Metabolic specialization drives reduced pathogenicity in Pseudomonas aeruginosa isolates from cystic fibrosis patients
PLOS Biology · 23.08.2024 · 22 (8) · e3002781
DOI: 10.1371/journal.pbio.3002781 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Biology, online erschienen am 23.08.2024. Verfasst von Bjarke Haldrup Pedersen und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kongens Lyngby, Denmark. Hauptthemen laut MEDLINE: Cystic Fibrosis, Pseudomonas aeruginosa, Pseudomonas Infections, Mutation. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Novo Nordisk Foundation, Independent Research Fund Denmark/Natural Sciences, Novo Nordisk Fonden.
Abstract (Originalsprache)
Metabolism provides the foundation for all cellular functions. During persistent infections, in adapted pathogenic bacteria metabolism functions radically differently compared with more naïve strains. Whether this is simply a necessary accommodation to the persistence phenotype or if metabolism plays a direct role in achieving persistence in the host is still unclear. Here, we characterize a convergent shift in metabolic function(s) linked with the persistence phenotype during Pseudomonas aeruginosa colonization in the airways of people with cystic fibrosis. We show that clinically relevant mutations in the key metabolic enzyme, pyruvate dehydrogenase, lead to a host-specialized metabolism together with a lower virulence and immune response recruitment. These changes in infection phenotype are mediated by impaired type III secretion system activity and by secretion of the antioxidant metabolite, pyruvate, respectively. Our results show how metabolic adaptations directly impinge on persistence and pathogenicity in this organism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kongens Lyngby, Denmark.
- Department of Clinical Microbiology 9301, Rigshospitalet, Copenhagen, Denmark.
- Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom.
- Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
ORCID-Profile: Ruggero La Rosa
Förderung
- Novo Nordisk Foundation
- Independent Research Fund Denmark/Natural Sciences
- Novo Nordisk Fonden
- Cystic Fibrosis Trust
- Danmarks Frie Forskningsfond
Zitieren
APA
Pedersen, B. H., Simões, F. B., Pogrebnyakov, I., Welch, M., Johansen, H. K., Molin, S., & La Rosa, R. (2024). Metabolic specialization drives reduced pathogenicity in Pseudomonas aeruginosa isolates from cystic fibrosis patients. PLOS Biology, 22(8), e3002781. https://doi.org/10.1371/journal.pbio.3002781
Vancouver
Pedersen BH, Simões FB, Pogrebnyakov I, Welch M, Johansen HK, Molin S, et al. Metabolic specialization drives reduced pathogenicity in Pseudomonas aeruginosa isolates from cystic fibrosis patients. PLOS Biology. 2024;22(8):e3002781. doi:10.1371/journal.pbio.3002781
BibTeX
@article{Pedersen2024,
author = {Pedersen, Bjarke Haldrup and Simões, Filipa Bica and Pogrebnyakov, Ivan and Welch, Martin and Johansen, Helle Krogh and Molin, Søren and La Rosa, Ruggero},
title = {Metabolic specialization drives reduced pathogenicity in Pseudomonas aeruginosa isolates from cystic fibrosis patients},
journal = {PLOS Biology},
year = {2024},
volume = {22},
number = {8},
pages = {e3002781},
doi = {10.1371/journal.pbio.3002781}
}
EUVIMED